Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) ended Monday session in green amid volatile trading. The shares closed up +5.18 points or 6.22% at $88.49 with 4.00 million shares getting traded. Post opening the session at $92.29, the shares hit an intraday low of $83.32 and an intraday high of $93.70 and the price vacillated in this range throughout the day. The company has a market cap of $1.97 billion and the numbers of outstanding shares have been calculated to be 262.58 million shares.
GW Pharmaceuticals PLC- ADR (GWPH) on June 27, 2016 announced positive results of the first randomized, double-blind, placebo-controlled Phase 3 clinical trial of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Lennox-Gastaut syndrome (LGS), a rare and severe form of childhood-onset epilepsy. In this trial, Epidiolex, when added as an adjunct to the patient’s current treatment, achieved the primary endpoint of a